VJOncology is committed to improving our service to you

ASCO 2019 | ASCO lung cancer highlights

VJOncology is committed to improving our service to you

Roy Herbst

Roy Herbst, MD, PhD, FACP, FASCO, of Yale University, New Haven, CT, discusses some of the key lung cancer updates presented at ASCO 2019, specifically mentioning treatments targeting KRAS and the drug ramucirumab. This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter